Extension Study from Confirmatory study in Pediatric Atopic Dermatitis Patients
Phase 3
- Conditions
- Atopic Dermatitis
- Registration Number
- JPRN-jRCT2080220142
- Lead Sponsor
- ovartis Pharma K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Inclusion Criteria
- Patients who had completed the core study and whose participation in this study was considered appropriate as judged by the investigator
- Patients whose guardians have given written informed consent to participation in this study
Exclusion Criteria
- Patients who failed in treatment compliance in the core study
- Patients who had a major violation of the protocol in the core study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method